NCT01965080View on ClinicalTrials.gov

Exemestane in Advanced and Recurrent Endometrial Carcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
Endometrial Cancer
Interventions
DRUG

Exemestane

One tablet Exemestane 25 mg daily

Trial Locations (1)

0310

The Norwegian Radium Hospital, Oslo

All Listed Sponsors
lead

Nordic Society of Gynaecological Oncology - Clinical Trials Unit

OTHER

NCT01965080 - Exemestane in Advanced and Recurrent Endometrial Carcinoma | Biotech Hunter | Biotech Hunter